Flagship explainer
What drives ARCUTIS BIOTHERAPEUTICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$16.1M | FY2025 |
| |
| Income before tax | −$15M | FY2025 |
|
| Operating income | −$12.2M | FY2025 |
|
| $372M | FY2025 |
| |
| Ending assets | $433M | FY2025 |
|
| Beginning assets | $349M | FY2024 |
|
| $189M | FY2025 |
| |
| $158M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001787306-26-000018